G

GeneBioTech Co Ltd
KOSDAQ:086060

Watchlist Manager
GeneBioTech Co Ltd
KOSDAQ:086060
Watchlist
Price: 4 085 KRW 0.12% Market Closed
Market Cap: 35.2B KRW

GeneBioTech Co Ltd
Cash from Operating Activities

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

GeneBioTech Co Ltd
Cash from Operating Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
G
GeneBioTech Co Ltd
KOSDAQ:086060
Cash from Operating Activities
â‚©3B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-3%
Celltrion Inc
KRX:068270
Cash from Operating Activities
â‚©812.1B
CAGR 3-Years
42%
CAGR 5-Years
22%
CAGR 10-Years
34%
P
PharmaResearch Co Ltd
KOSDAQ:214450
Cash from Operating Activities
â‚©162.4B
CAGR 3-Years
33%
CAGR 5-Years
43%
CAGR 10-Years
26%
Alteogen Inc
KOSDAQ:196170
Cash from Operating Activities
â‚©82.2B
CAGR 3-Years
N/A
CAGR 5-Years
30%
CAGR 10-Years
52%
A
ABL Bio Inc
KOSDAQ:298380
Cash from Operating Activities
-â‚©33.2B
CAGR 3-Years
2%
CAGR 5-Years
-13%
CAGR 10-Years
N/A
D
DND PharmaTech Inc
KOSDAQ:347850
Cash from Operating Activities
-â‚©21.8B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

GeneBioTech Co Ltd
Glance View

Market Cap
35.2B KRW
Industry
Biotechnology

Gene Bio Tech Co., Ltd. engages in the manufacture of fermented biomass. The company is headquartered in Gongju, Chungcheongnam-Do. The company went IPO on 2006-04-28. is a company mainly engaged in the production and sale of feed additives and animal drugs. Along with subsidiaries, the Company operates its business through two segments. The Additive segment is involved in the manufacturing and sale of fermented products and bio starches. The Animal Drug segment is involved in the manufacturing and sale of livestock and fish medicine. The main products include vitamins, minerals, antibiotics, nutrients, immune stimulators, digestion and absorption promoters, among others. The firm distributes its products within the domestic market and to overseas markets, including America.

Intrinsic Value
10 418.82 KRW
Undervaluation 61%
Intrinsic Value
Price
G

See Also

What is GeneBioTech Co Ltd's Cash from Operating Activities?
Cash from Operating Activities
3B KRW

Based on the financial report for Jun 30, 2025, GeneBioTech Co Ltd's Cash from Operating Activities amounts to 3B KRW.

What is GeneBioTech Co Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
-3%

Over the last year, the Cash from Operating Activities growth was 44%.

Back to Top